Asthma and Beta-blockers

Overview

Journal Eur J Clin Pharmacol

Specialty Pharmacology

Date 1982 Jan 1

PMID 6127219

Citations 7

Authors

D S Lawrence

J N Sahay

S S Chatterjee

J M Cruickshank

Affiliations

Soon will be listed here.

Abstract

In a randomized, blind crossover study in 14 hypertensive patients with asthma, involving placebo and chronically administered (3 weeks) equipotent beta1-blocking doses of atenolol 100 mg once daily and metoprolol 100 mg bid, atenolol and metoprolol produced a similar fall in blood pressure. Atenolol caused significantly (p less than 0.05) less bronchospasm in terms of fewer asthmatic attacks, more asthma-free days, less frequent sensations of moderate to very severe, wheeziness and less effect on the evening peak flow rate. It was concluded that, in patients with asthma who require beta blockade, atenolol is the preferred agent, co-prescribed with a beta2 stimulant.

Citing Articles

Vidarabine, an anti-herpes agent, improves Porphyromonas gingivalis lipopolysaccharide-induced cardiac dysfunction in mice.

Tsunoda M, Matsuo I, Ohnuki Y, Suita K, Ishikawa M, Mitsubayashi T J Physiol Sci. 2023; 73(1):18.

PMID: 37558983 PMC: 10717078. DOI: 10.1186/s12576-023-00873-5.

Vidarabine, an anti-herpes agent, prevents occlusal-disharmony-induced cardiac dysfunction in mice.

Hayakawa Y, Suita K, Ohnuki Y, Mototani Y, Ishikawa M, Ito A J Physiol Sci. 2022; 72(1):2.

PMID: 35148678 PMC: 10717220. DOI: 10.1186/s12576-022-00826-4.

Sympathetic activity in breast cancer and metastasis: partners in crime.

Conceicao F, Sousa D, Paredes J, Lamghari M Bone Res. 2021; 9(1):9.

PMID: 33547275 PMC: 7864971. DOI: 10.1038/s41413-021-00137-1.

Atenolol in the treatment of essential hypertension.

Piddisi C, Cerskus I Can Fam Physician. 2011; 32:1802-6.

PMID: 21267286 PMC: 2328151.

Cardioselective beta-blocker use in patients with reversible airway disease.

Salpeter S, Ormiston T, Salpeter E Cochrane Database Syst Rev. 2001; (2):CD002992.

PMID: 11406056 PMC: 8689715. DOI: 10.1002/14651858.CD002992.

References

Decalmer P, Chatterjee S, Cruickshank J, Benson M, STERLING G . Beta-blockers and asthma. Br Heart J. 1978; 40(2):184-9. PMC: 482795. DOI: 10.1136/hrt.40.2.184. View

Cruickshank J . Once-daily dosing with Atenolol in patients with mild or moderate hypertension. Br Med J. 1976; 1(6016):990-1. PMC: 1639643. DOI: 10.1136/bmj.1.6016.990. View

Majid P, van der Vijgh W, de Feijter P, Wardeh R, van der Wall E, ROOS J . Once daily atenolol (Tenormine) in the treatment of angina pectoris. Observations on clinical efficacy, pharmacokinetics and pharmacodynamics. Eur J Cardiol. 1979; 9(6):419-35. View

Johnsson G, SVEDMYR N, Thiringer G . Effects of intravenous propranolol and metoprolol and their interaction with isoprenaline on pulmonary function, heart rate and blood pressure in asthmatics. Eur J Clin Pharmacol. 1975; 8(3-4):175-80. DOI: 10.1007/BF00567111. View

Lyngstam O, Ryden L . Metoprolol or atenolol for mild-to-moderate hypertension. Lancet. 1979; 2(8143):634. DOI: 10.1016/s0140-6736(79)91690-8. View

Barber J . Relative activity of atenolol and metoprolol. Br Med J. 1978; 2(6133):357. PMC: 1606451. DOI: 10.1136/bmj.2.6133.357-a. View

Benson M, Berrill W, Cruickshank J, Sterling G . A comparison of four beta-adrenoceptor antagonists in patients with asthma. Br J Clin Pharmacol. 1978; 5(5):415-9. PMC: 1429350. DOI: 10.1111/j.1365-2125.1978.tb01647.x. View

SIMPSON W . Nature and incidence of unwanted effects with atenolol. Postgrad Med J. 1977; 53 Suppl 3:162-7. View

Wale J, Fitzgerald J . Assessment and clinical implications of cardioselectivity. Proc R Soc Med. 2010; 70(Suppl 5):45-7. PMC: 1542847. View

10.

Vilsvik J, SCHAANNING J . Effect of atenolol on ventilatory and cardiac function in asthma. Br Med J. 1976; 2(6033):453-5. PMC: 1687593. DOI: 10.1136/bmj.2.6033.453. View

11.

Harry J, Shields A . Relative activity of atenolol and metoprolol. Br Med J. 1978; 2(6130):128. PMC: 1605876. DOI: 10.1136/bmj.2.6130.128. View

12.

AStrom H, Vallin H . Effect of a new beta-adrenergic blocking agent, ICI 66o82, on exercise haemodynamics and airway resistance in angina pectoris. Br Heart J. 1974; 36(12):1194-1200. PMC: 458942. DOI: 10.1136/hrt.36.12.1194. View

13.

Harry J, Cruickshank J, Young J . Once-daily deta-blockers and blood-pressure response to exercise. Lancet. 1979; 2(8136):250. DOI: 10.1016/s0140-6736(79)90262-9. View

14.

AStrom H . Comparison of the effects on airway conductance of a new selective beta-adrenergic blocking drug, atenolol, and propranolol in asthmatic subjects. Scand J Respir Dis. 1975; 56(6):292-6. View

15.

Jackson G, Schwartz J, Kates R, Winchester M, Harrison D . Atenolol: once-daily cardioselective beta blockade for angina pectoris. Circulation. 1980; 61(3):555-60. DOI: 10.1161/01.cir.61.3.555. View

16.

Kendall M, John V, Quarterman C, Welling P . A single and multiple dose pharmacokinetic and pharmacodynamic comparison of conventional and slow-release metroprolol. Eur J Clin Pharmacol. 1980; 17(2):87-92. DOI: 10.1007/BF00562615. View

17.

Jeffers T, Webster J, Petrie J, Barker N . Atenolol once-daily in hypertension. Br J Clin Pharmacol. 1977; 4(5):523-7. PMC: 1429154. DOI: 10.1111/j.1365-2125.1977.tb00780.x. View

18.

McDevitt D . The assessment of beta-adrenoceptor blocking drugs in man. Br J Clin Pharmacol. 1977; 4(4):413-25. PMC: 1429044. DOI: 10.1111/j.1365-2125.1977.tb00756.x. View

19.

COMERFORD M, Besterman E . Relative activity of atenolol and metoprolol. Br Med J. 1977; 2(6081):260. PMC: 1631350. DOI: 10.1136/bmj.2.6081.260. View

20.

Ormerod L, Stableforth D . Asthma mortality in Birmingham 1975-7: 53 deaths. Br Med J. 1980; 280(6215):687-90. PMC: 1600791. DOI: 10.1136/bmj.280.6215.687. View